Clearmind Medicine Inc. Equity And Liabilities
Clearmind Medicine Inc. (CMND) had Equity And Liabilities of $11.14 million as of 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2026-03-12
- 2023-01-31: Equity And Liabilities 6.21M CAD.
- 2022-10-31: Equity And Liabilities 1.13M CAD.
- 2021-10-31: Equity And Liabilities 5.16M CAD.
CAD
| Period end | Equity And Liabilities |
|---|---|
| 2023-01-31 | 6.21M CAD 6-K · filed 2023-03-17 |
| 2022-10-31 | 1.13M CAD 6-K · filed 2023-03-17 |
| 2021-10-31 | 5.16M CAD 20-F · filed 2023-02-06 |
USD
| Period end | Equity And Liabilities |
|---|---|
| 2026-01-31 | $11.14M 6-K · filed 2026-03-12 |
| 2025-10-31 | $6.08M 6-K · filed 2026-03-12 |
| 2025-07-31 | $3.97M 6-K · filed 2025-09-11 |
| 2025-04-30 | $5.18M 6-K · filed 2025-06-12 |
| 2025-01-31 | $6.58M 6-K · filed 2025-03-13 |
| 2024-10-31 | $7.26M 20-F · filed 2026-01-20 |
| 2024-07-31 | $8.17M 6-K · filed 2024-09-16 |
| 2024-04-30 | $8.85M 6-K · filed 2024-06-13 |
| 2024-01-31 | $10.10M 6-K · filed 2024-03-19 |
| 2023-10-31 | $5.95M 20-F · filed 2025-01-22 |
| 2023-04-30 | $6.00M 6-K · filed 2023-06-14 |
| 2022-10-31 | $826.41K 20-F/A · filed 2024-03-18 |